Cargando…
Virtual Screening, Biological Evaluation, and 3D-QSAR Studies of New HIV-1 Entry Inhibitors That Function via the CD4 Primary Receptor
Human immunodeficiency virus type 1 (HIV-1) is responsible for the majority of HIV infections worldwide, and we still lack a cure for this infection. Blocking the interaction of HIV-1 and its primary receptor CD4 is one strategy for identifying new anti-HIV-1 entry inhibitors. Here we report the dis...
Autores principales: | Zhang, Chaozai, Zhang, Huijun, Huang, Lina S., Zhu, Siyu, Xu, Yan, Zhang, Xing-Quan, Schooley, Robert T., Yang, Xiaohong, Huang, Ziwei, An, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278378/ https://www.ncbi.nlm.nih.gov/pubmed/30463393 http://dx.doi.org/10.3390/molecules23113036 |
Ejemplares similares
-
Discovery and Computational Analyses of Novel Small Molecule Zika Virus Inhibitors
por: Zhu, Siyu, et al.
Publicado: (2019) -
Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening
por: Kirstgen, Michael, et al.
Publicado: (2021) -
Evaluation of QSAR Equations for Virtual Screening
por: Spiegel, Jacob, et al.
Publicado: (2020) -
Synergistic inhibition of hepatitis C virus infection by a novel microtubule inhibitor in combination with daclatasvir
por: Zhang, Huijun, et al.
Publicado: (2022) -
QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery
por: Neves, Bruno J., et al.
Publicado: (2018)